Skip Navigation


The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Bookmark | Print | E-Mail

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic e-mail notifications as soon as a clinical trial is posted in the medical category you're interested in.






Home » Drug Information » FDA-Approved Drugs » 2002
Medical Areas: Immunology/Infectious Diseases | Pediatrics/Neonatology

View By: Year Company Therapeutic Areas Drug Names 

Drug Information

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Drug Name: Fluzone Preservative-free

Company: Sanofi Pasteur
Approval Status: Approved September 2002
Treatment Area: Influenza immunization in infants

General Information

The preservative-free formulation of the Fluzone Influenza Virus Vaccine was approved in September 2002 to immunize high-risk and normal infants, aged six months to 35 months.

Fluzone is also available in its non-preservative-free formulation for pediatric and adult patients.

Additional Information

For further information about Fluzone, visit the Aventis Pasteur vaccine product web site at www.vaccineshoppe.com.


Jobson Medical Information

Copyright © 1995-2009 Jobson Medical Information LLC.


Designed by Piehead Productions LLC.